Glooko, a US-based maker of a mobile diabetes management system focused on making glucose data accessible to both patients and clinicians, has raised $7m series A-1 funding from new investors including Samsung Venture Investment Corporation, the investment management company for semiconductor and consumer electronics company Samsung, and Lifeforce Ventures, as well as existing investors including The Social + Capital Partnership, Sundeep Madra and Yogen Dalal.
Rick Altinger, Glooko’s chief executive officer, said: “Over the last two years, Glooko has built a diabetes management infrastructure bent on liberating blood glucose data from glucose meters and making it accessible to patients and clinicians. Our next steps are to scale Glooko’s system to global accessibility and to add a layer of analytics and messaging capable of making therapeutic recommendations for diabetes management.”
Glooko’s system includes an app, a metersync cable and a web dashboard. mobile device. The mobile apps integrate into the existing Glooko diabetes management web dashboards, which enable healthcare professionals and care management teams to remotely monitor and identify at risk patients.